Larimar Therapeutics, Inc. (LRMR) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 8 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for LRMR is $12.00, representing a +146.4% upside from the current price of $4.87. Price targets range from a low of $12.00 to a high of $12.00.
